Language | English |
---|---|
Edited by | Gary Lyman |
Publication details | |
History | 1983-present |
Publisher | |
Frequency | 10/year |
2.218 (2014) | |
Standard abbreviations | |
ISO 4 | Cancer Investig. |
NLM | Cancer Invest |
Indexing | |
ISSN | 0735-7907 (print) 1532-4192 (web) |
Links | |
Cancer Investigation is a peer-reviewed medical journal in the field of basic and clinical oncology. [1] The editor in chief is Gary Herbert Lyman. [2] It is currently indexed for MEDLINE.
Saccharin, also called saccharine, benzosulfimide, or E954, or used in saccharin sodium or saccharin calcium forms, is a non-nutritive artificial sweetener. Saccharin is a sultam that is about 500 times sweeter than sucrose, but has a bitter or metallic aftertaste, especially at high concentrations. It is used to sweeten products, such as drinks, candies, baked goods, tobacco products, excipients, and for masking the bitter taste of some medicines. It appears as white crystals and is odorless.
The National Cancer Institute (NCI) coordinates the United States National Cancer Program and is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The NCI conducts and supports research, training, health information dissemination, and other activities related to the causes, prevention, diagnosis, and treatment of cancer; the supportive care of cancer patients and their families; and cancer survivorship.
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts. Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
Advaxis Inc. is an American company devoted to the discovery, development and commercialization of immunotherapies based on a technology platform which uses engineered Listeria monocytogenes. The company is headquartered in Princeton, New Jersey and was incorporated in Delaware in 2006.
Current Eye Research is a medical journal covering all areas of ophthalmology. Areas covered include: clinical research, anatomy, physiology, biophysics, biochemistry, pharmacology, developmental biology, microbiology, and immunology
The Journal of Obstetrics and Gynaecology is an international peer-reviewed medical journal that publishes original research and review articles on the entire field of obstetrics and gynecology, with an emphasis on practical applicability. The journal publishes a wide range of papers, including scientific and clinical research, reviews, case reports, and supplements on clinical symposia.
Mitochondrial DNA is an academic journal that publishes review articles on the current and developing technologies around mitochondrial DNA research and discovery. It is published by Informa Healthcare.
Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.
Amyloid: the Journal of Protein Folding Disorders is a peer-reviewed scientific journal that publishes original research and review articles on all aspects of the protein groups and associated disorders that are classified as amyloidoses as well as other disorders associated with abnormal protein folding. The Journal has a major focus on etiology, pathogenesis, histopathology, chemical structure and the nature of fibrillogenesis and also publishes papers on the genetic aspects of many of these disorders. It is the official journal of the International Society of Amyloidosis. The Journal was established in 1994 as AMYLOID: The International Journal of Experimental & Clinical Investigation until the change of name in 2004. The impact factor in 2017 was 4.048. Dr. Alan Cohen was the founding editor and from 1994 until 2010 the first Editor-in-Chief of Amyloid: The Journal of Protein Folding Disorders. The present editor in chief is Per Westermark.
The COPD: Journal of Chronic Obstructive Pulmonary Disease is a peer-reviewed medical journal that covers all aspects of chronic obstructive pulmonary disease and its related conditions.
Experimental Lung Research is a peer-reviewed medical journal that publishes original articles in all fields of respiratory tract anatomy, biology, developmental biology, toxicology, and pathology. The editor-in-chief is Mark Giembycz. According to the Journal Citation Reports, the journal has a 2010 impact factor of 1.069, ranking it 38th out of 46 journals in the category "Respiratory System".
The International Journal of Hyperthermia and Thermal Therapies is a peer-reviewed medical journal and the official journal of the Society for Thermal Medicine, the European Society for Hyperthermic Oncology, and the Japanese Society of Hyperthermic Oncology. It covers research and clinical studies and trials on hyperthermia and other thermal therapies which fall largely into the three main categories of clinical studies, biological studies, and physics/engineering studies on techniques of heat delivery and temperature measurement. Starting June 2018, the journal became a fully Open Access Journal.
International Reviews of Immunology is an international peer-reviewed medical journal that covers basic and translational research in immunology and related fields.
The Journal of Maternal-Fetal and Neonatal Medicine is a peer-reviewed medical journal that covers obstetric, medical, genetic, mental health, and surgical complications of pregnancy and their effects on the mother, fetus, and neonate. Research on audit, evaluation, and clinical care in maternal-fetal and perinatal medicine is also featured. It is the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, and the International Society of Perinatal Obstetricians.
Systems Biology in Reproductive Medicine is a peer-reviewed medical journal that covers the use of systems approaches including genomic, cellular, proteomic, metabolomic, bioinformatic, molecular, and biochemical, to address fundamental questions in reproductive biology, reproductive medicine, and translational research. The journal publishes research involving human and animal gametes, stem cells, developmental biology, toxicology, and clinical care in reproductive medicine.
Pediatric Hematology and Oncology is an international peer-reviewed medical journal that covers all aspects of pediatric hematology and oncology. The journal covers immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems.
Seminars in Ophthalmology is a peer-reviewed medical journal which publishes clinically oriented reviews on the diagnosis and treatment of ophthalmic disorders. Each issue focuses on a single topic, with a primary emphasis on appropriate surgical techniques.
Ultrastructural Pathology is a bimonthly peer-reviewed medical journal devoted entirely to diagnostic ultrastructural pathology. The journal covers advances in the uses of electron microscopic and immunohistochemical techniques, correlations of ultrastructural data with light microscopy, histochemistry, immunohistochemistry, biochemistry, cell and tissue culturing, electron probe analysis, and investigative, clinical, and diagnostic EM methods. The editor-in-chief is Jahn M. Nesland.
Neuro-Ophthalmology is an English language, peer-reviewed medical journal that covers diagnostic methods in neuro-ophthalmology such as visual fields, CT scanning and electrophysiology, the visual system such as the retina, oculomotor system, pupil, neuro-ophthalmic aspects of the orbit, and related fields such as migraine and ocular manifestations of neurological diseases.
The Clyde cancer cluster was a childhood cancer cluster located in and around Clyde, Ohio, United States. The cluster was classified by the Ohio Department of Health in 2009. In an 11-year interval, ten childhood cancers were documented in an area where 5.3 were expected, and four pediatric brain and central nervous system cancers were reported, in an area where 0.92 were expected. According to the ODH, the odds of this happening without a common cause are less than 1 in 20. No known commonality exists between the cases, and despite years of investigation no cause has been found.